CORVUS PHARMACEUTICALS INC (CRVS)
US2210151005 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -27.03M | -41.31M | -43.24M | -6.00M | -46.67M | |||
| Depreciation Amortization | 151.00K | 370.00K | 460.00K | 630.00K | 740.00K | |||
| Change In Working Capital | -3.59M | 1.41M | -3.24M | 1.91M | 1.90M | |||
| Other non cash items | 6.54M | 12.51M | 9.30M | -31.32M | 6.70M | |||
| OPERATING CASH FLOW | -23.93M | -27.02M | -36.72M | -34.78M | -37.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -34.00K | -270.00K | -10.00K | -80.00K | -30.00K | |||
| Other Investing Activity | 15.57M | -23.01M | 21.57M | 44.85M | 3.28M | |||
| INVESTING CASH FLOW | 15.54M | -23.28M | 21.56M | 44.77M | 3.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 7.86M | 0.00 | 62.16M | 1.31M | 20.00K | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 7.86M | 0.00 | 62.16M | 1.31M | 20.00K | |||
| CHANGE IN CASH | -539.00K | -50.30M | 47.00M | 11.30M | -34.04M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -23.93M | -27.02M | -36.72M | -34.78M | -37.32M | |||
| Capital Expenditure | -34.00K | -270.00K | -10.00K | -80.00K | -30.00K | |||
| FREE CASH FLOW | -23.97M | -27.29M | -36.73M | -34.86M | -37.35M | |||
All data in USD